INNO-LiPA® HPV Genotyping Extra II

Line probe assay, based on the reverse hybridization principle, designed for the identification of 32 different genotypes of the human papillomavirus (HPV).

  • Individual identification of 32 genotypes.
  • One genotype = one probe line.
  • Ready-to-use mastermix.
  • Automation.
  • Primer mix for RT-PCR application.
  • Cervical cells, first-void urine and formalin-fixed paraffin-embedded tissue (CE).
INNO-LiPA® HPV Genotyping Extra II

Product number 81534

20 Tests
INNO-LiPA® HPV Genotyping Extra II Amplification

Product number 81533

20 Tests
CE marked (IVDR)
Please contact your local Fujirebio representative for the availability of this product in your country.

Click here to navigate

  • Details
  • Conditions of sale
  • Citations
  • Documentation
  • Insights
  • Related products
  • Webinars

  • Details


    Features and benefits

    Full genotyping

    • Simultaneous detection of 32 HPV genotypes.
    • SPF10 Plus provides high test sensitivity due to the precision of the short 65-base pair PCR product, even in case of degraded DNA (FFPE samples), low viral load and mixed HPV infection.1,2,3
    • SPF10 Plus permits simultaneous detection of multiple genotypes in a single sample.

    Built-in controls

    • Special HPV control lines to confirm and detect the presence of a broad range of mucosal HPV genotypes plus additional controls to monitor sample processing (hDNA line, conjugate control line).

    Streamlining

    • Easy and ready-to-use master mix, with Taq DNA polymerase provided for minimum manipulation steps and hands-on time.

    CE Applications:

    • Cervical cells collected in Surepath medium or PreservCyt medium.
    • First-void urine with preservative.
    • Formalin-fixed paraffin embedded (FFPE) material.

    RUO Applications:

    • HPV Primer Mix SPF10 Plus for Real-Time PCR application.

    Automation

    • Auto-LiPA™ 48: up to 48 tests per run from sample incubation to color development.
    • AutoBlot 3000H: up to 20 tests per run from sample incubation to color development.
    • TENDIGO®: up to 10 tests per run from sample incubation to color development.
    • Results within +/- 3 hours.
    • Minimum hands-on time, accurate results.
    • Interpretation software for complete traceability.

     
    References

    1. Xu L. et al. Clinical Evaluation of INNO-LiPA HPV Genotyping Extra II Assay Using the VALGENT Framework. Int J Mol Sci. 2018; 19(9), 2704
    2. Ahmadi S. et al. Human Papilloma Virus Genotype Distribution in Cervical lesions in Zanjan, Iran. Asian Pac J Cancer Prev. 2017; 18(12):3373-3377
    3. Sohrabi et al. Is incidence of multiple HPV genotypes rising in genital infections? J Infect Public Health. 2017; 10(6):730-733

  • Conditions of sale

    To read the end user conditions of sale for this product please visit our Resource center.

  • Citations

    The BIOZ badges associated with Fujirebio products include peer-reviewed citations derived from scientific studies using Fujirebio products. Please note that the peer-reviewed citations do not reflect the regulatory status of Fujirebio products. Users should refer to the specific product documentation and any (clinical) claims made therein in order to ensure compliant use. For each country or geographic region, users must verify the related regulatory status of the Fujirebio product.

  • Insights

    • Review past webinars

    HPV
    Replay available
    2020/11/26 - 26 November 2020

    First void urine & HPV genotyping

    Watch replay

Veuillez confirmer que vous êtes un professionnel de la santé

Le contenu de ce site web est en partie réservé aux professionnels de santé qui sont directement impliqués dans la fourniture de services de soins de santé aux patients. Si vous êtes un professionnel de santé et que vous disposez de tous les droits d'accès, veuillez confirmer en cliquant sur le bouton 'oui'.

Choose your country or region

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.
The content of this website is in part restricted to healthcare professionals who are directly involved in the provision of healthcare services to patients. If you are a health professional and you have full access rights, please check this box and confirm below.